Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen
The objective of this first-in-human study is to assess the safety and effectiveness of the Serranator Sonic Intravascular Lithotripsy (IVL) System™ for the treatment of peripheral artery disease.
Subject is ≥ 18 years of age [+9]
Rutherford Clinical Categories 0, 1, 5 and 6 [+19]